Johnson Health Tech .Co., Ltd. (TPE:1736)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
123.00
-7.50 (-5.75%)
Apr 2, 2026, 1:30 PM CST

Johnson Health Tech .Co. Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
54,32947,78538,07033,61330,779
Revenue Growth (YoY)
13.69%25.52%13.26%9.21%8.51%
Cost of Revenue
26,85923,50719,64219,00716,873
Gross Profit
27,47024,27818,42714,60613,906
Selling, General & Admin
22,63419,74615,98613,89012,559
Research & Development
1,1701,1471,062913.22808.65
Operating Expenses
23,87821,08617,18514,82113,752
Operating Income
3,5923,1921,242-214.93154.19
Interest Expense
-380.52-349.8-377.47-256.18-163.48
Interest & Investment Income
351311.52194.19165.17152.41
Currency Exchange Gain (Loss)
293.35330.82363.44970.59-96.88
Other Non Operating Income (Expenses)
80.3129.19-63.71-132.2790.84
EBT Excluding Unusual Items
3,9363,5141,359532.38137.08
Gain (Loss) on Sale of Investments
3.28-14.89-15.23-226.3923.18
Gain (Loss) on Sale of Assets
-9.08-6.32-9.05-2.383.44
Pretax Income
3,9303,4921,334303.61163.7
Income Tax Expense
1,1801,062625.0578.6764.33
Earnings From Continuing Operations
2,7502,431709.44224.9499.37
Minority Interest in Earnings
-0.62-0.470.39204.08-61.22
Net Income
2,7492,430709.83429.0238.15
Net Income to Common
2,7492,430709.83429.0238.15
Net Income Growth
13.14%242.36%65.45%1024.63%-94.38%
Shares Outstanding (Basic)
303303303303303
Shares Outstanding (Diluted)
304303303303303
Shares Change (YoY)
0.11%0.11%0.10%0.01%-0.02%
EPS (Basic)
9.068.022.341.420.13
EPS (Diluted)
9.068.012.341.420.13
EPS Growth
13.11%242.31%65.06%1024.49%-94.37%
Free Cash Flow
869.97379.783,193-15.32-4,229
Free Cash Flow Per Share
2.871.2510.54-0.05-13.98
Dividend Per Share
-4.0001.0000.6000.500
Dividend Growth
-300.00%66.67%20.00%-55.36%
Gross Margin
50.56%50.81%48.40%43.45%45.18%
Operating Margin
6.61%6.68%3.26%-0.64%0.50%
Profit Margin
5.06%5.09%1.86%1.28%0.12%
Free Cash Flow Margin
1.60%0.80%8.39%-0.05%-13.74%
EBITDA
4,2243,8521,812323.24637.49
EBITDA Margin
7.77%8.06%4.76%0.96%2.07%
D&A For EBITDA
631.98660.37569.66538.17483.3
EBIT
3,5923,1921,242-214.93154.19
EBIT Margin
6.61%6.68%3.26%-0.64%0.50%
Effective Tax Rate
30.02%30.40%46.84%25.91%39.30%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.